Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-14

Clinical Trial Update: Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery [Phase 3]

View source ↗

Summary

Phase 3 trial update on mouth-dissolving mosapride tables aimed at improving gut recovery after cesarean delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mosapride (mosapride)

Snippet

Sponsor: Benha University | Conditions: Prevention of Postoperative Ileus | Phase 3 | Status: COMPLETED